Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report)’s share price was down 4.6% on Thursday after UBS Group lowered their price target on the stock from $30.00 to $27.00. UBS Group ...

Teva has agreed to pay a whopping $1.2 billion to settle a US lawsuit claiming its subsidiary Cephalon paid to hold up generic competition to its narcolepsy therapy Provigil.

Teva Pharmaceutical Industries Ltd. and Samsung Bioepis Co., Ltd. announced that they entered into a licensing ...

The management of Israeli pharma group Teva has laid out its strategy for a return to growth after a challenging few years, with a greater emphasis on innovative medicines and a focus on complex ...

Bank of America chose Teva Pharmaceutical Industries Ltd. as one of its top picks in its biopharma survey, while Cantor Fitzgerald chose website building platform company Wix.com Ltd. as a top ...

Drugmakers Teva Pharmaceutical (TEVA) and Sanofi (SNY) announced earlier today that their experimental antibody therapy, duvakitug, showed impressive results in a clinical trial for patients with ...